Composite metabolic indices for the assessment of early biochemical and metabolic alterations in Iraqi children and adolescents with type 1 diabetes: an exploratory case–control study
- 1Department of Pathological Analyses, FacultyofScience, University of Kufa
Abstract
To evaluate hepatic, renal, and lipid biomarkers together with composite metabolic indices for identifying early metabolic alterations and metabolic risk assessment in Iraqi children and adolescents with type 1 diabetes (T1D). A case–control study was conducted involving 100 children and adolescents with T1D and 100 age-and sex-matched healthy controls. Biochemical parameters were measured, and composite indices including atherogenic index of plasma (AIP), triglyceride-glucose index (TyG), fatty liver index (FLI), and De Ritis ratio were calculated. Receiver operating characteristic (ROC) analysis, Subgroup analyses, and multivariable logistic regression were used to investigate discriminatory performance and independent associations. Significant alterations in renal, hepatic, and lipid biomarkers were observed in T1D patients (p < 0.05). Composite indices demonstrated excellent discriminating power (AUC 0.92–0.97). Exploratory subgroup analyses suggested that patients receiving lipid-lowering therapy exhibited lower values of several composite metabolic indices, whereas RAS blockers use was associated with lower renal-related indices. Composite metabolic indices, particularly TyG, FLI, and AIP, may provide complementary exploratory markers of early metabolic and biochemical alterations in pediatric T1D. These findings require validation in larger prospective multicenter studies before clinical application.
Related
- Pathomic Texture Composites from H&E, and Immunohistochemistry of Prostatectomy Specimens for Exploratory Modeling of Time to Biochemical Recurrence
- Salivary biochemical, immunological, and microbiological alterations associated with cigarette, IQOS, and e-cigarette use
- Impact of aldehyde dehydrogenase 2 polymorphism on lipid profile alterations in alcohol-abstinent adolescents stratified by steatotic liver disease status
- Composite inflammatory indices and incident lung cancer risk in an exploratory statistical mediation analysis
- An exploratory simulation of the optimization of leukocyte transmigration, indicating that barrier routing is governed by context-dependent biochemical cues rather than hardwired programs
BibTeX
@article{abed2026composite,
title = {{Composite metabolic indices for the assessment of early biochemical and metabolic alterations in Iraqi children and adolescents with type 1 diabetes: an exploratory case–control study}},
author = {Sajad Abbas Abed and Dhifaf Zeki Aziz},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-62647-4},
url = {https://doi.org/10.1038/s41598-026-62647-4},
note = {CC BY},
}
RIS
TY - JOUR
TI - Composite metabolic indices for the assessment of early biochemical and metabolic alterations in Iraqi children and adolescents with type 1 diabetes: an exploratory case–control study
AU - Sajad Abbas Abed
AU - Dhifaf Zeki Aziz
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-62647-4
UR - https://doi.org/10.1038/s41598-026-62647-4
AB - To evaluate hepatic, renal, and lipid biomarkers together with composite metabolic indices for identifying early metabolic alterations and metabolic risk assessment in Iraqi children and adolescents with type 1 diabetes (T1D). A case–control study was conducted involving 100 children and adolescents with T1D and 100 age-and sex-matched healthy controls. Biochemical parameters were measured, and composite indices including atherogenic index of plasma (AIP), triglyceride-glucose index (TyG), fatty liver index (FLI), and De Ritis ratio were calculated. Receiver operating characteristic (ROC) analysis, Subgroup analyses, and multivariable logistic regression were used to investigate discriminatory performance and independent associations. Significant alterations in renal, hepatic, and lipid biomarkers were observed in T1D patients (p < 0.05). Composite indices demonstrated excellent discriminating power (AUC 0.92–0.97). Exploratory subgroup analyses suggested that patients receiving lipid-lowering therapy exhibited lower values of several composite metabolic indices, whereas RAS blockers use was associated with lower renal-related indices. Composite metabolic indices, particularly TyG, FLI, and AIP, may provide complementary exploratory markers of early metabolic and biochemical alterations in pediatric T1D. These findings require validation in larger prospective multicenter studies before clinical application.
SN - 2045-2322
ER -